SEC Form 4 · accession 0001237899-15-000027
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael S Aberman
Officer — SVP Strategy Investor Relation
Period of report
Mar 23, 2015
Accepted (ET)
Mar 25, 2015 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 23, 2015 | F | 5,157 | $476.50 | D | 17,341 | D | |
| Common StockF2 | Mar 24, 2015 | S | 300 | $474.79 | D | 17,041 | D | |
| Common StockF3 | Mar 24, 2015 | S | 200 | $475.83 | D | 16,841 | D | |
| Common StockF4 | Mar 24, 2015 | S | 740 | $476.53 | D | 16,101 | D | |
| Common StockF5 | Mar 24, 2015 | S | 573 | $477.59 | D | 15,528 | D | |
| Common StockF6 | Mar 24, 2015 | S | 530 | $478.46 | D | 14,998 | D | |
| Common StockF7 | Mar 24, 2015 | S | 500 | $479.39 | D | 14,498 | D | |
| Common StockF8 | Mar 24, 2015 | S | 800 | $480.70 | D | 13,698 | D | |
| Common StockF9 | Mar 24, 2015 | S | 1,100 | $481.59 | D | 12,598 | D | |
| Common Stock | Mar 24, 2015 | S | 100 | $482.56 | D | 12,498 | D | |
| Common Stock | holding | — | — | — | 407 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- F2Represents volume-weighted average price of sales of 300 shares of Company stock on March 24, 2015 at prices ranging from $474.50 to $474.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 24, 2015 at each separate price.
- F3Represents volume-weighted average price of sales of 200 shares of Company stock on March 24, 2015 at prices ranging from $475.79 to $475.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 24, 2015 at each separate price.
- F4Represents volume-weighted average price of sales of 740 shares of Company stock on March 24, 2015 at prices ranging from $476.21 to $476.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 24, 2015 at each separate price.
- F5Represents volume-weighted average price of sales of 573 shares of Company stock on March 24, 2015 at prices ranging from $477.11 to $477.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 24, 2015 at each separate price.
- F6Represents volume-weighted average price of sales of 530 shares of Company stock on March 24, 2015 at prices ranging from $478.03 to $478.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 24, 2015 at each separate price.
- F7Represents volume-weighted average price of sales of 500 shares of Company stock on March 24, 2015 at prices ranging from $479.09 to $479.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 24, 2015 at each separate price.
- F8Represents volume-weighted average price of sales of 800 shares of Company stock on March 24, 2015 at prices ranging from $480.12 to $480.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 24, 2015 at each separate price.
- F9Represents volume-weighted average price of sales of 1,100 shares of Company stock on March 24, 2015 at prices ranging from $481.03 to $481.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 24, 2015 at each separate price.